News releases related to this initiative

The NTDs Drug-discovery Research Consortium

1) Joint drug discovery research for anti-protozoan drugs

July 2012, "Tokyo Institute of Technology and Astellas: Start of Joint Drug Discovery Research for Neglected Tropical Diseases caused by Protozoan Parasites - Through use of Tokyo-Tech's Supercomputer TSUBAME2.0"

September 2012, "KEK and Astellas begin collaborative research to discover new drugs for neglected tropical diseases - Design of pharmaceuticals based on the three-dimensional structure of proteins using synchrotron X-ray crystallography"

November 2012, "Nagasaki University and Astellas Launch Collaborative Research for Screening New Anti-Protozoan Drugs for Neglected Tropical Diseases - Selection of Potential Compounds by Evaluation of Anti-Protozoan activities"

November 2012, "University of Tokyo and Astellas Enter Collaborative Research for Target Discovery of New Drugs for Neglected Tropical Diseases Caused by Protozoan Parasites - Selection of Target Molecular for Drug Discovery by Verifications on the Validity of Target Candidates"

2) Joint drug discovery research for anti-dengue virus drugs

March 2013, "Nagasaki University and Astellas Launch Collaborative Research for Screening New Anti-Dengue Virus Drugs for Neglected Tropical Diseases"

March 2013, "Tokyo Institute of Technology and Astellas Launch Collaborative Research for New Anti-Dengue Virus Drugs for Neglected Tropical Diseases"

Development of Drug Discovery Database for NTDs

Development of pediatric formulation for Schistosomiasis

March 2014, "Pediatric Praziquantel Consortium awarded US$1.86 million GHIT grant"

July 2012, "New public-private partnership to develop a treatment for schistosomiasis-infected preschool children"

Participation in Global Health Innovative Technology Fund (GHIT Fund)

2013 April, "Participation in "Global Health Innovative Technology Fund (GHIT Fund)""

2017 Jun, "Commitments to GHIT Fund Replenishment"